The lower expression of ACE2 and TMPRSS2 with inhaled corticosteroid use warrants prospective study of inhaled corticosteroid use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity (Peters et al., 2020). The gene discussed is ACE2; the disease is COVID-19.